Literature DB >> 1101814

In vitro studies with combinations of 5-fluorocytosine and amphotericin B.

S Shadomy, G Wagner, E Espinel-Ingroff, B A Davis.   

Abstract

Synergistic antifungal activity of 5-fluorocytosine (5-FC) and amphotericin B was studied using an abbreviated checkerboard titration scheme. 5-FC was titrated in twofold increments (100 to 0.05 mug/ml) in the absence and presence of graded increments of amphotericin B (1.0. 0.5, 0.1, 0.05, and 0.01 mug/ml) in buffered yeast nitrogen base. A limited number of experiments were performed using expanded dual titration checkerboard schemes and growth curve studies. Forty-eight isolates of yeastlike organisms were tested; two were inhibited by the buffer system. Evidence of synergy, as indicated by a fourfold or greater reduction of the minimal inhibitory concentration of 5-FC in the presence of subinhibitory concentrations of amphotericin B, was seen with 11 of 46 isolates, or 24%, at the fungistatic level and with three isolates, or 7% at the fungicidal level. Indifferent results were obtained for 44 and 74% of the isolates, respectively, at the fungistatic and fungicidal levels. Antagonism was observed with three isolates.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101814      PMCID: PMC429277          DOI: 10.1128/AAC.8.2.117

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.

Authors:  E R Block; J E Bennett
Journal:  Proc Soc Exp Biol Med       Date:  1973-02

2.  Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. II. Studies on distribution and incorporation.

Authors:  A Polak; H J Scholer
Journal:  Pathol Microbiol (Basel)       Date:  1973

3.  Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.

Authors:  G Medoff; M Comfort; G S Kobayashi
Journal:  Proc Soc Exp Biol Med       Date:  1971-11

4.  Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.

Authors:  J D Hamilton; D M Elliott
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

5.  Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.

Authors:  E Titsworth; E Grunberg
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

6.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

  6 in total
  23 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

Authors:  M A Ghannoum; M S Motawy; M A Abu Hatab; A S Ibrahim; R S Criddle
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.

Authors:  Patrick Schwarz; Guilhem Janbon; Françoise Dromer; Olivier Lortholary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.

Authors:  Patrick Schwarz; Françoise Dromer; Olivier Lortholary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Amphotericin B and filipin effects on L and HeLa cells: dose response.

Authors:  J Kotler-Brajtburg; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

6.  Impregnated disk method for antifungal antibiotic testing.

Authors:  J E Boyer
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

7.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

8.  Cryptococcal meningitis.

Authors:  T L Tjia; Y K Yeow; C B Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

9.  Experimental Candida albicans endocarditis: characterization of the disease and response to therapy.

Authors:  M A Sande; C R Bowman; R A Calderone
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

10.  In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.

Authors:  C E Hughes; C Harris; J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.